Get the Stockscreener App
14.61
0.01%
0.001
Burning Rock Biotech Ltd Adr stock is traded at $14.61, with a volume of 2,270.
It is up +0.01% in the last 24 hours and up +25.09% over the past month.
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
See More
Previous Close:
$14.61
Open:
$14.61
24h Volume:
2,270
Relative Volume:
0.11
Market Cap:
$154.09M
Revenue:
$72.33M
Net Income/Loss:
$-8.38M
P/E Ratio:
-18.54
EPS:
-0.7881
Net Cash Flow:
$-4.95M
1W Performance:
-3.88%
1M Performance:
+25.09%
6M Performance:
-28.93%
1Y Performance:
+80.61%
1-Day Range:
$14.61
$14.61
1-Week Range:
$13.87
$15.82
52-Week Range:
$6.79
$41.72
Burning Rock Biotech Ltd Adr Stock (BNR) Company Profile
Name
Burning Rock Biotech Ltd Adr
Sector
Industry
Phone
-
Address
-
Compare BNR vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNR
Burning Rock Biotech Ltd Adr
|
14.61 | 154.09M | 72.33M | -8.38M | -4.95M | -0.7881 |
TMO
Thermo Fisher Scientific Inc
|
679.17 | 251.12B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
228.20 | 160.42B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
396.72 | 57.18B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
174.86 | 49.30B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
264.13 | 43.48B | 16.63B | 1.39B | 2.12B | 8.0674 |
Burning Rock Biotech Ltd Adr Stock (BNR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jul-07-20 | Initiated | Cowen | Outperform |
Burning Rock Biotech Ltd Adr Stock (BNR) Latest News
Burning Rock Q2FY26 Results: Revenue falls 9.3% YoY, in-hospital segment grows - scanx.trade
Burning Rock Biotech (BNR) Earnings Date and Reports 2026 $BNR - marketbeat.com
Aesthetic Medical International Holdings Group Ltd (AIH) Peer Comparison – Compare with Others - Value Research
Concord Medical Services Holdings LimitedADR Peer Comparison – Compare with Others - Value Research
Burning (BNR) Earnings Report: EPS Exceeds Its Estimate; After Earnings: Shares Finish 2.10% Lower in the Available RecordRevenue Guidance Range - careplusvn.com
Burning Rock Biotech Ltd StockBNR Share Price Today, News and Discussion - Stocktwits
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 3.7%What's Next? - MarketBeat
Burning Rock Biotech (BNR) Slides 4% as Biotech Sentiment Wavers — Key Levels in FocusBreakout Stock Alerts - dars.gov.et
Price to sales forward of Burning Rock Biotech Ltd. Sponsored ADR – FWB:6BU0 - TradingView
Burning Rock Biotech (BNR) Holds at $8.90: Precision Oncology Stock Tests Key Trading RangeDouble Bottom - careplusvn.com
Burning Rock Biotech (BNR) Holds at $8.90: Precision Oncology Stock Tests Key Trading RangeVolatility Surface - dars.gov.et
Burning Rock Biotech (BNR) Holds at $8.90: Precision Oncology Stock Tests Key Trading RangeFibonacci Retracement - dars.gov.et
Burning Rock Biotech (BNR) Edges Higher as Biotech Sentiment StabilizesPrice Surge Stocks - careplusvn.com
Burning Rock Biotech (BNR) Edges Higher as Biotech Sentiment StabilizesChannel Breakout - dars.gov.et
Burning Rock Biotech (BNR) Edges Higher as Biotech Sentiment StabilizesEarly Entry Signals - dars.gov.et
BNR Q3 2022 Earnings: EPS Beat Justifies Caution as Revenue Remains UndisclosedQuarterly Profit Report - careplusvn.com
BNR Q3 2022 Earnings: EPS Beat Justifies Caution as Revenue Remains UndisclosedShort-Term Outlook - dars.gov.et
Burning Rock Biotech Limited Sponsored ADR $BNR Shares Sold by Crcm LP - MarketBeat
Price to sales forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Enterprise value to EBITDA forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Enterprise value to revenue forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Burning Rock CEO purchases $618,218 in company shares - Investing.com
Burning Rock Founder and CEO Yusheng Han Purchases 73,141 ADSs in Open Market, Bringing Total to 145,874 Across Three Post-Earnings Windows - Quiver Quantitative
Burning Rock Announces Founder’s Purchase of Its ADSs - Barchart.com
Burning Rock Biotech Ltd. Sponsored ADR Financial Disclosures & Filings - TradingView
Enterprise value to EBIT forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Enterprise value to revenue forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Price to book forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Price to earnings forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Burning Rock Biotech Ltd. Sponsored ADR Actuals & Estimates (NASDAQ:BNR) - TradingView
Burning Rock Biotech Ltd. Sponsored ADR Actuals & Estimates (LS:A40AE6) - TradingView
Why These High-Flying Stocks Came Back To Earth - Sahm
BNRBurning Rock Biotech Ltd ADR Stock Price and Quote - Finviz
Which countries contribute most to Burning Rock (BNR) revenue? (Overhead Buying) 2026-05-01Momentum ETF - newsline.com
ETFs Investing in Burning Rock Biotech Ltd. Sponsored ADR Stocks - TradingView
Which countries contribute most to Burning Rock (BNR) revenue? (Overhead Buying) 2026-05-01Viral Momentum Stocks - Newser
Burning Rock Biotech Limited Sponsored ADR (NASDAQ:BNR) Short Interest Update - MarketBeat
Earnings BeforeStock ScreenerSnapshot - Finviz
Burning Rock Biotech (NASDAQ: BNR) 2025 loss narrows amid China and HFCAA risks - Stock Titan
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 1.3%What's Next? - MarketBeat
Cancer screening company Faces Tough IPO Test As Market Cools - Benzinga
Aurelion Inc. appoints Yuki Xu as acting chief accounting officer By Investing.com - Investing.com South Africa
Aurelion Inc. appoints Yuki Xu as acting chief accounting officer - Investing.com
Burning Rock Biotech (NASDAQ:BNR) Director Purchases $5,466,143.20 in Stock - MarketBeat
Burning Rock CEO purchases $546,604 in company shares - Investing.com
Burning Rock CEO purchases $546,604 in company shares By Investing.com - Investing.com India
Burning Rock Announces Founder’s Purchase of Its ADSs - Barchart.com
Burning Rock Biotech Limited CEO Yusheng Han Purchases 31,487 ADSs, Demonstrating Confidence in Company’s Future - Quiver Quantitative
Burning Rock Biotech (BNR) Expected to Announce Earnings on Tuesday - MarketBeat
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 9.8%Here's What Happened - MarketBeat
Burning Rock Biotech Ltd Adr Stock (BNR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Burning Rock Biotech Ltd Adr Stock (BNR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Han Yusheng | Director |
Jun 26 '26 |
Buy |
8.00 |
24,900 |
199,090 |
18,404,086 |
| Han Yusheng | Director |
Jun 23 '26 |
Buy |
7.50 |
5,990 |
44,920 |
18,129,186 |
| Han Yusheng | Director |
Jun 22 '26 |
Buy |
7.45 |
104,650 |
779,674 |
18,123,196 |
| Han Yusheng | Director |
Jun 16 '26 |
Buy |
9.00 |
111,110 |
999,957 |
18,018,546 |
| Han Yusheng | Director |
Jun 12 '26 |
Buy |
9.25 |
210,000 |
1,942,143 |
17,907,436 |
| Han Yusheng | Director |
Jun 11 '26 |
Buy |
8.74 |
24,760 |
216,388 |
17,697,436 |
| Han Yusheng | Director |
Mar 31 '26 |
Buy |
17.36 |
314,870 |
5,466,143 |
17,672,676 |
1.90%
6.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):